Cognition Therapeutics: Funding, Investors & Team (Aug 2026)
A neuroscience business called Cognition Therapeutics, Inc. is now in the trial stages of researching medications to aid in restoring normal cellular damage responses in neurodegenerative and neuro-ophthalmic illnesses.
Cognition Therapeutics has raised $6.0M across 1 funding round on record, the most recent an undisclosed round of $6.0M announced in Nov 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cognition Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Cognition Therapeutics Funding Rounds
Cognition Therapeutics Founders and Leadership Team
Contact details for the Cognition Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Cognition Therapeutics Funding Compared to Other Biotechnology Startups
Cognition Therapeutics' latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cognition Therapeutics in Biotechnology and Pittsburgh
Companies Similar to Cognition Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Cognition Therapeutics Funding FAQs
What does Cognition Therapeutics do?
A neuroscience business called Cognition Therapeutics, Inc. is now in the trial stages of researching medications to aid in restoring normal cellular damage responses in neurodegenerative and neuro-ophthalmic illnesses.
How much funding has Cognition Therapeutics raised?
Cognition Therapeutics has raised $6.0M across 1 round on record. The most recent is an undisclosed round of $6.0M announced in Nov 2022.
When did Cognition Therapeutics last raise funding?
Cognition Therapeutics' most recent funding round on record is an undisclosed round of $6.0M, announced in Nov 2022.
Who is the CEO of Cognition Therapeutics?
Lisa Ricciardi is listed as CEO at Cognition Therapeutics.
Where is Cognition Therapeutics headquartered?
Cognition Therapeutics is based in Pittsburgh, Pennsylvania, United States.
How many employees does Cognition Therapeutics have?
Cognition Therapeutics is in the 51-100 employee band.
How does Cognition Therapeutics' funding compare to other Biotechnology startups?
Cognition Therapeutics' latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Cognition Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cognition Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.